Edit |   |
Product Name | Recombinant MERS-CoV Spike protein |
Description | Domain: 18-1296aa. Recombinant MERS-CoV Spike, fused to His-tag at C-terminus, was expressed in insect cell and purified by using conventional chromatography techniques. MW: 141.6kDa(1285aa). Purity > 85% by SDS - PAGE. MERS-CoV, which causes the Middles East Respiratory Syndrome (MERS), belongs to a family of viruses known as coronaviruses. MERS-CoV was first identified in the Kingdom of Saudi Arabia in 2012, which is a single and positive stranded RNA virus. Dromedary camels are widely considered as the source of the transmission of MERS-CoV. The rate of human transmission among household contacts of MERS patients has been approximately 5 % based on serological analysis. MERS-CoV has four structural proteins, known as the S (spike), E (envelope), M (membrane), and N (nucleocapsid) proteins. The spike protein, responsible for allowing the virus to attach to and fuse with the membrane of a host cell and is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion. MERS-CoV S mediates viral attachment and fusion to human cells via human cellular receptor DPP4, also known as CD26. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity |
Size | 10ug, 20ug, 50ug, 100ug, 250ug, 500ug, 1mg |
Concentration | 0.25mg/ml (determined by Bradford assay) |
Applications | SDS-PAGE, Bioactivity |
Other Names | Middle East respiratory syndrome coronavirus, Human betacoronavirus 2c EMC/2012, MERS-CoV, MERS, MERS-CoV SP, Spike glycoprotein, S glycoprotein, S, Spike protein |
Gene, Accession, CAS # | NCBI: AFS88936, UniProt: K0BRG7 |
Catalog # | ATGP4112 |
Price | $120, $220, $290, $480, $850, $1450, $2420 |
Order / More Info | Recombinant MERS-CoV Spike protein from NKMAX Co. Ltd. |
Product Specific References | Goo J, et al. Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein. (Virus Res. 2020){https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114870/} |